Principal Securities Inc. Acquires 982 Shares of Enovis Co. (NYSE:ENOV)

Principal Securities Inc. increased its holdings in Enovis Co. (NYSE:ENOV) by 21.0% in the fourth quarter, HoldingsChannel reports. The firm owned 5,649 shares of the company’s stock after purchasing an additional 982 shares during the period. Principal Securities Inc.’s holdings in Enovis were worth $248,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. UMB Bank n.a. boosted its holdings in Enovis by 128.2% in the fourth quarter. UMB Bank n.a. now owns 778 shares of the company’s stock worth $34,000 after purchasing an additional 437 shares in the last quarter. Pinnacle Bancorp Inc. boosted its holdings in Enovis by 54.5% in the fourth quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company’s stock worth $37,000 after purchasing an additional 300 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new stake in Enovis in the third quarter worth $55,000. FMR LLC boosted its holdings in Enovis by 20.5% in the third quarter. FMR LLC now owns 2,840 shares of the company’s stock worth $122,000 after purchasing an additional 484 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in Enovis during the third quarter valued at about $217,000. 98.45% of the stock is currently owned by institutional investors.

Enovis Stock Down 2.6 %

ENOV stock opened at $42.77 on Monday. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12. Enovis Co. has a 52-week low of $38.27 and a 52-week high of $65.03. The company has a 50-day moving average of $45.08 and a two-hundred day moving average of $44.38. The stock has a market capitalization of $2.43 billion, a price-to-earnings ratio of -19.53 and a beta of 1.94.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC restated a “buy” rating and set a $65.00 price target on shares of Enovis in a report on Thursday, November 7th.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.